PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
28-Jun-2020 ReNeuron signs new exosome research collaboration ReNeuron Group plc
28-Jun-2020 Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline ENTEROME SA
28-Jun-2020 Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases AbbVie
28-Jun-2020 Chi-Med Announces US$100 Million Equity Investment by General Atlantic Chi-Med
28-Jun-2020 UK precision medicine company PrecisionLife identifies 68 genes associated with high risk of severe COVID-19, suggesting opportunities for genomic biomarkers and new treatment options PrecisionLife
28-Jun-2020 SNF472 Mechanism of Action data published in British Journal of Pharmacology Sanifit
25-Jun-2020 Panthera Biopartners appoints Chris Dodd as Executive VP of Business Development – Oncology and CNS Panthera Biopartners
25-Jun-2020 Panthera and Rutherford Health launch innovative oncology clinical trial network Panthera Biopartners
24-Jun-2020 Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program Scenic Biotech
24-Jun-2020 UK’s MHRA renews EAMS Scientific Opinion for Santhera’s Idebenone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
24-Jun-2020 HAND SANITISER SPIKE IS HERE TO STAY, SAYS BCMPA BCMPA
24-Jun-2020 PureTech Founded Entity Karuna Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for KarXT for the Treatment of Acute Psychosis in Patients with Schizophrenia PureTech Health plc
24-Jun-2020 Oculis to Present at the Upcoming Virtual European Biotech Investor Day 2020 Oculis
24-Jun-2020 MSF calls on Gavi to revise its global mechanism and demand pharma sell all COVID-19 vaccines at cost Gavi
24-Jun-2020 BioGeneration Ventures Closes BGV IV Fund at €105 Million BioGeneration Ventures
24-Jun-2020 GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (voxelotor) to Treat Sickle Cell Patients in Europe Global Blood Therapeutics, Inc.
24-Jun-2020 Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHill’s Opaganib Compared to Matched Case-Control Group RedHill Biopharma
24-Jun-2020 THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE Amryt Pharma Plc
24-Jun-2020 GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug GW Pharmaceuticals plc
24-Jun-2020 Roivant Sciences continues its partnership with BaseLaunch for Phase II Roivant Sciences